# Mined Therapeutics, Inc. — Form D

Mined Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-27. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-09-27
- Form: D
- Accession: 0001884272-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 18
- Date of first sale: 2021-09-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414680

## Issuer

- Name: Mined Therapeutics, Inc.
- CIK: 0001884272
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2021
- Address: 245 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-595-5769

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Alex Koglin | Director | Santa Fe, NM |
| Thomas Nickoloff | Director | Champaign, IL |
| ANDREW SANDFORD | Director | Cambridge, MA |
| David Seldin | Director | Boston, MA |
| ANDREW SANDFORD | Executive Officer | Cambridge, MA |

## More

- [CIK 1884272 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1884272&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001884272-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.